SecBot SecBot
SECBOTREPLAY Home › Report › ASND

ASND · Jean-Jacques Bienaime, a director or significant insider of Ascendis…

Ascendis Pharma A/S · 3 filed Apr 1, 2026 at 16:10 ET

At the news

NEUTRALIMPACT 2/10

3 filed Apr 1, 2026 at 16:10 ET

Jean-Jacques Bienaime, a director or significant insider of Ascendis Pharma, filed a Form 3 to report initial beneficial ownership of 9,160 ordinary shares and 172.35 warrants exercisable into shares, with a power of attorney granted to several executives to file SEC reports on his behalf. This is a routine initial filing for ownership disclosure and does not indicate any change in holdings or strategic direction.

  • Jean-Jacques Bienaime filed Form 3 to report initial beneficial ownership as of March 23, 2026
  • He holds 9,160 ordinary shares (including ADSs) and 172.35 warrants
  • Warrants vest 25% on June 10, 2026, then in 36 equal monthly installments through 2035
  • Power of attorney granted to six company executives, including CEO, CFO, and CLO, to file SEC forms on his behalf

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access